ACTRN12613001222730
已完成
3 期
A phase III study to investigate the effect of daily ingestion of four then two Kivia (Trademark) 575mg Zyactinase (Registered Trademark) or placebo capsules on stool frequency and abdominal pain severity when given to subjects with constipation dominant Irritable Bowel Syndrome
Vital Food Processors Ltd0 个研究点目标入组 180 人2013年11月6日
概览
- 阶段
- 3 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Constipation dominant Irritable Bowel Syndrome (IBS-C)
- 发起方
- Vital Food Processors Ltd
- 入组人数
- 180
- 状态
- 已完成
- 最后更新
- 6年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Subjects diagnosed with IBS\-C according to Rome III criteria Abdominal pain intensity in past 24 hour score of \>3\.0 using VAS scale during screening
- •Subject swith Fewer than 3 Complete Spontaneous Bowel Movements per week during screening
排除标准
- •Diarrhoea predominant or alternating IBS
- •Significant GI condition or serious systemic illness
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
Western Australian ATOM pilot study : Atropine for the treatment of myopiaACTRN12617000598381ions Eye Institute153
招募中
1 期
[68Ga]Ga-PentixaFor-PET imaging for staging of marginal zone lymphomaMarginal Zone LymphomaMedDRA version: 20.0Level: PTClassification code: 10076596Term: Marginal zone lymphoma Class: 100000004864Therapeutic area: Diseases [C] - Neoplasms [C04]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]CTIS2022-500918-25-00Pentixapharm GmbH148
尚未招募
2 期
Effect of ayurvedic medicine drvyadi rasakriya in diabetesCTRI/2023/01/049263Aushadhi Bhavan
尚未招募
2 期
A clinical trial to study the effects of 2 formulations, Darvi rasakriya and Yashtimadhu rasakriya in the treatment of Mukhapaka (Aphthous stomatitis)CTRI/2022/05/042947Balan R
已完成
1 期
A programme to develop a skin patch containing two medicines (physostigmine and hyoscine), Study 8: Assessment of effects of consecutive 24-hour applications of patches for 21 days on the blood levels of the two medicines and any associated symptoms in healthy male and female participantsPotential risk of poisoning by nerve agentInjury, Occupational Diseases, PoisoningISRCTN62968791Defence Science and Technology Laboratory54